Aquinox Pharmaceuticals Inc.

(AQXP) Trade

By |

Profile

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a regulator of a cellular signaling pathway in immune cells. The company's product candidate includes AQX-1125, which is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder. All the business activity of the group is functioned through United States.

Contact Information

Website: www.aqxpharma.com
Email: ir@aqxpharma.com
Main Phone: +1 604 629-9223
Address: 887 Great Northern Way
Address 2: Suite 450
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V5T 4T5

Issuer Information

Exchange: NSD
CEO: David J. Main
Employees: 52
NAICS: Pharmacies and Drug Stores(446110)
$ 2.32 $ -0.005 (-0.22%)
Last Price 2.32 Change $ -0.005 Change % -0.22 Tick N/A
Bid 0.10 Bid Size 100.00 Ask 2.49 Ask Size 100.00
Open 2.31 High 2.35 Low 2.30 Prev Close 2.33
Last Trade Volume 18,026 52 Wk Hi 16.90 52 Wk Low 1.96
Market Cap 54.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 23,537,368.00 EPS (TTM) -1.83 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 2
Number of Buys 0 1
Number of Sells 0 1
Net Activity 0 0
Last 10 Buys Shares
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
Lloyd Mackenzie 1,000
David J. Main 1,000
David J. Main 1,000
David J. Main 1,000
Lloyd Mackenzie 1,000
Kamran Alam 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 28 28 28 28
Low Target Price Estimate 26 26 26 26
Mean Target Price Estimate 27 27 27 27
Standard Deviation 1.41 1.41 1.41 1.41
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1